Recommended NZ | Guide to Money | Gimme: Competitions - Giveaways

New asthma guidelines to relieve Kiwi sufferers

Fuseworks Media
Fuseworks Media

It is estimated that nearly half a million New Zealanders take medication for asthma, including approximately 1 in every 9 adults.

With the right treatment and education, symptoms including wheezing, shortness of breath, chest tightness and coughing can usually be prevented.

Despite this, more than one New Zealander dies per week from asthma and many more suffer daily because of asthma symptoms.

New guidelines have now been introduced by New Zealand experts specifically for kiwis with asthma to help reduce these statistics.

The New Zealand asthma management guidelines were launched as part of the 2016 respiratory conference, 24-25 November.

It’s been nearly 15 years since new guidelines were introduced and there have been important changes to the way we treat asthma says Waikato District Health Board (DHB) respiratory specialist, Dr Cat Chang.

Waikato DHB specialist Dr Cat Chang performing a lung funtion test on patient

"One key area of new asthma management is the development of combining maintenance and relief therapy into a single inhaler. Until now, patients had to use at least two different inhalers: one, or sometimes two, inhalers for maintenance treatment and another for symptom relief.

"Our Waikato Respiratory Unit are collaborating with other centres in New Zealand and globally in the NovelSTART study that has the potential to improve people’s lives with a simple yet more effective treatment plan for their asthma.

"We still have a lot of unanswered questions about the best use of combination inhalers and we rely on local asthma volunteers to help us answer them and advance the best possible care."

The Waikato Respiratory Unit need volunteers with asthma who currently use the blue reliever inhaler to test the theory that asthma control can be improved by taking a single combination inhaler when needed; over the traditional approach of taking preventer inhalers every day and using a separate inhaler for asthma symptoms.

The study runs for 12 months and involves around 7 visits to the hospital. Participants will receive study related medication free of charge and be reimbursed for reasonable travel costs for each study visit.

All articles and comments on have been submitted by our community of users. Please notify us if you believe an item on this site breaches our community guidelines.